RAAS targeting drugs Flashcards
Ramipril drug type
ACE inhibitor (angiotensin converting enzyme)
Valsartan drug type
ARB (Angiotensin receptor blockers)
Spironolactone Drug type
MRA (mineralocorticoid receptor antagonists)
What accumulates with ace inhibitors and its consequence
vasoactive peptides (Bradykinin) which lead to dry cough
Where does ACE inhibition occur
endothelial cells throughout circulation
3 uses of ace inhibitors and how
High BP (vasodilator, lower aldosterone)
Chronic Kidney disease (lower renal pressure)
Heart failure and ischemic heart disease (lower effects of angiotensin 2 and aldosterone on damaged muslce)
Cautions of ACE inhibitor
Reduced BP
Dry cough
Hyperkalemia (High K from aldosterone inhibition)
Lowered kidney perfusion in vulnerable patients
What do ARBs inhibit
AT-1 receptor, blocks angiotensin 2
(same action as ACE, different target)
What are ACEI and ARB first-line agents for
Chronic kidney disease (before other BP drugs)
How to ACEI and ARBs do renal protection
RAAS is high and causes lots of extra pressure, RAAS will increase amount of proteins leaking.
These drugs work to reduce pressure and damage progression
Kidney Effect Cautions of ACEI and ARB
-vulnerable patient with poor renal flow (dehydrated), renin levels will increase. causing aldosteron release and fluid retention
-can cause acute renal failure
Direct renin inhibitors MOA
Bind to active site of renin and block conversion of angiotensinogen to angiotensin 1
Uses of MRA
-specific CV situations
-resistant hypertension (excess aldosterone)
-heart failure (block aldosterone)
MRA cautions
-increase K from RAAS blocking
-hormonal effect of gynecomastia tissue growth